A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- T. Akshaya, T. Senthil Kumar, R. Yogeshwari, S. Sridevi, N. Venkatesh, Chemotherapy-Induced Changes in Body Composition among Breast Cancer Patients: A Scoping Review , Journal of Cancer Research Updates: Vol. 14 (2025)
- Asmaa M. Elkady, Doaa A. Yousef, Mona M. Watany, Fatma Gharib, Efficacy of Melatonin Oral Gel in Reducing Oral Mucositis in Patients with Head and Neck Cancer under Chemoradiation , Journal of Cancer Research Updates: Vol. 14 (2025)
- Praneet Singh Bedi, Meenu Walia, Vipulkumar Thummar, Priya Mehta, A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting , Journal of Cancer Research Updates: Vol. 12 (2023)
- Sh.R. Kzyrgalin, K.Sh. Gantsev, A.A. Rizvanov, Sh.Kh. Gantsev, New Insight of Oncology: Cancer Concept without Tumor , Journal of Cancer Research Updates: Vol. 13 (2024)
- Ali Muafaq Said, Ayat Ali Salih, Mohammed Abdulridha Obid, Azal Hamoody Jumaa, Youssef Shakuri Yasin, A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA/CoA Ratio via Dual Inhibition of PPAT and CPT1A , Journal of Cancer Research Updates: Vol. 14 (2025)
- G.R. Nivashini, Lalatendu Moharana, Ashish Jawarkar, Komal Parashar, Tarun Parashar, Dinesh Kumar Yadav, Targeting Inflammatory Pathways in Cancer: Novel Insights into Tumorigenesis and Personalized Therapeutic Approaches , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Christopher Krauss, Chelsey Aurelius, Kayla Johnston, Victoria Bartlette, Sherrita Gavin, Jazmine Cuffee, Satyendra Banerjee, Sarah Wiseniewsky, Santosh Mandal, Hirendra Nath Banerjee, An Investigation to Study the Role of Novel Rhenium Compounds on Endometrial Uterine Cancer Cell Lines , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran, A.E. Mega, Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Lisa Billecke, Eva Maria Murga Penas, Jozef Zustin, Thorsten Derlin, Carsten Bokemeyer, Georgia Schilling, Extramedullary Plasmacytoma of the Lung - Rather a Disseminated than a Localized Disease? - A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Parvin Mehdipour, Evolutionary Hypothesis in Cell Cycle of Breast Cancer Patients: Mosaic Phases in Single Cancer Cells , Journal of Cancer Research Updates: Vol. 11 (2022)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)